CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.57B, above the global median of $1.18B
- FinancialsAltman Z-Score 5.08: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.57BUSDvs all stocks (USD)
Revenue (TTM)
830.44MUSDvs all stocks (USD)
Profit Margin
-13.23%Beta
0.5600xvs all stocks
52-Week Change
-3.41%vs all stocks
Market Capitalization
2.57BUSDvs all stocks (USD)
Enterprise Value
2.28BUSDvs all stocks (USD)
Forward P/E
9.91xPrice to Sales (TTM)
3.10xPrice to Book (MRQ)
2.49xEnterprise to Revenue
2.74xEnterprise to EBITDA
20.62xGross Margin
84.63%Profit Margin
-13.23%Operating Margin
-2.48%Return on Assets (TTM)
0.39%Return on Equity (TTM)
-10.49%Revenue (TTM)
830.44MUSDvs all stocks (USD)
Revenue per Share (TTM)
14.46USDUpdated Aug 28, 2026Quarterly Revenue Growth
32.40%Gross Profit (TTM)
605.31MUSDvs all stocks (USD)
EBITDA (TTM)
67.95MUSDvs all stocks (USD)
Net Income (TTM)
-109.89MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
32.40%Operating Cash Flow (TTM)
19.91MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
84.61MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Aug 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
718.95MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
74.56MUSDFY2025 · Dec 31, 2025Gross Profit
644.39MUSDFY2025 · Dec 31, 2025Operating Income
-36.86MUSDvs all stocks (USD)
Pre-tax Income
-49.03MUSDFY2025 · Dec 31, 2025Income Tax Expense
-10.48MUSDFY2025 · Dec 31, 2025Net Income
-38.55MUSDFY2025 · Dec 31, 2025EBIT
-49.03MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
67.95MUSDFY2025 · Dec 31, 2025Research & Development
106.23MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
485.56MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
13.25MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
0.00USDFY2025 · Dec 31, 2025EPS (Basic)
-0.6800USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.6800USDFY2025 · Dec 31, 2025Basic Shares Outstanding
56.45MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
56.45MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-38.55MUSDFY2025 · Dec 31, 2025Operating Cash Flow
67.28MUSDFY2025 · Dec 31, 2025Free Cash Flow
65.94MUSDDerived from operating cash flow minus capital expenditure. This filing charges 91.56M of depreciation against 1.34M of capital expenditure, and its own free-cash-flow line reads 45.99M.FY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
129.90MUSDFY2025 · Dec 31, 2025Income Tax Paid
16.05MUSDFY2025 · Dec 31, 2025Interest Paid
0.00USDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-38.55MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
91.56MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
5.21MUSDFY2025 · Dec 31, 2025Stock-based Compensation
33.05MUSDFY2025 · Dec 31, 2025Other Non-cash Items
30.38MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-22.30MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-24.57MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-7.50MUSDFY2025 · Dec 31, 2025Capital Expenditures
-1.34MUSDFY2025 · Dec 31, 2025Net Acquisitions
-293.09MUSDFY2025 · Dec 31, 2025Purchase of Investments
-475.94MUSDFY2025 · Dec 31, 2025Sale of Investments
774.48MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
4.11MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-28.49MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
9.13MUSDFY2025 · Dec 31, 2025Shares Outstanding
58.16MSharesUpdated Aug 28, 2026Float Shares
51.65MSharesUpdated Aug 28, 2026Shares Short
4.15MSharesUpdated Aug 28, 2026Short Ratio
4.42daysvs all stocks
Short % of Shares Outstanding
8.76%vs all stocks
% Held by Insiders
4.49%vs all stocks
% Held by Institutions
106.66%vs all stocks
Total Cash (MRQ)
372.07MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
6.40USDUpdated Aug 28, 2026Total Debt (MRQ)
40.17MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0389xCurrent Ratio (MRQ)
2.08xBook Value per Share (MRQ)
17.73USDUpdated Aug 28, 2026Total Assets
1.45BUSDvs all stocks (USD)
Total Current Assets
644.18MUSDFY2025 · Dec 31, 2025Total Liabilities
390.93MUSDFY2025 · Dec 31, 2025Total Non-current Assets
808.47MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
52.76MUSDFY2025 · Dec 31, 2025Total Current Liabilities
338.17MUSDFY2025 · Dec 31, 2025Cash
56.37MUSDFY2025 · Dec 31, 2025Cash Equivalents
72.08MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
128.45MUSDFY2025 · Dec 31, 2025Other Short-term Investments
180.22MUSDFY2025 · Dec 31, 2025Accounts Receivable
187.80MUSDFY2025 · Dec 31, 2025Inventory
82.39MUSDFY2025 · Dec 31, 2025Accounts Payable
2.68MUSDFY2025 · Dec 31, 2025Short-term Debt
10.61MUSDFY2025 · Dec 31, 2025Other Current Liabilities
69.27MUSDFY2025 · Dec 31, 2025Long-term Debt
30.36MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
22.40MUSDFY2025 · Dec 31, 2025Common Stock (Book)
57.00KUSDFY2025 · Dec 31, 2025Retained Earnings
517.88MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
1.06BUSDvs all stocks (USD)
52-Week Low
42.45USDUpdated Aug 28, 202652-Week High
59.68USDUpdated Aug 28, 202652-Week Change
-3.41%vs all stocks
Beta
0.5600xvs all stocks
50-Day MA
46.73USDUpdated Aug 28, 2026200-Day MA
48.55USDUpdated Aug 28, 2026Avg 10-Day Volume
518.36KSharesUpdated Aug 28, 2026Avg 30-Day Volume
848.05KSharesUpdated Aug 28, 2026Diluted EPS (TTM)
-1.90USDUpdated Aug 28, 2026Other Income / Expense
-25.42MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.85Profit Margin: -0.13
Financial Health
Altman Z-Score 5.08: safe zoneNotable
Altman Z-Score: 5.08
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.57B, above the global median of $1.18BNotable
Market cap (USD): 2,570,443,964Global Median: 1,179,398,897.704
Revenue is $830.44M, above the global median of $534.05MNotable
Revenue (USD): 830,438,016Global Median: 534,052,387.958
Levered free cash flow is $84.61M, above the global median of $19.23MNotable
Levered free cash flow (USD): 84,611,000Global Median: 19,234,564.734
Companies that share the same coordination system — how they create, deliver, or capture value.
Precigen Inc.
Tier 1ProductionApproval-Gated PipelineRule
Neogen Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Biohaven Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Guangzhou Innogen Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Trevi Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ultragenyx Pharmaceutical Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Nektar Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pharvaris N.V.
Tier 1ProductionApproval-Gated PipelineRuleRisk
GN Store Nord A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shandong Buchang Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule